Karl is the US VP of Sales for Pfizer Ophthalmics and Endocrine Care Division. He is based in New York City at Pfizer’s world headquarters where he leads these two specialized sales teams. These sales teams are the highest percent gross profit generating sales forces for Pfizer. Karl’s focus on evidence based sales messaging, strong team work between sales and marketing all coupled with relentless focus on execution has driven his success.

He was a leader of the US pre-launch teams for both Xalatan and Macugen. He led the sales organization to the blockbuster launch of both products. Xalatan is the number one selling Ophthalmic pharmaceutical product both in the US as well as globally with sales in excess of $1.4B. He repeated this success with Macugen’s successful launch in 2005, placing Macugen in the top 10 percent of pharma launches since 1985.  

Since joining Pfizer, Karl has been the recipient of the 2006 Upjohn Award for his “Focus on Performance”. This was his second Upjohn award with the first being presented while with Pharmacia in 2001. He is the only two time recipient of this top corporate honor.

Prior to joining Pfizer, Karl was a VP of Sales and Marketing with Pharmacia Ophthalmology and has been in the Ophthalmology business for over 22 years. During his tenure with Pharmacia, he had P&L responsibility, strategic planning responsibility and launched two products as head of marketing. Also, he has sold medical capital equipment and medical devices in his 26 year career in medical sales and marketing. Karl holds two Bachelor’s degrees from Michigan State University.  

Karl brings 27 plus years’ experience in the health care business. He has been credited with personal contributions to achieving impressive results — sales growth, modernization, culture change, competitive positioning, profitability and value.

David Ridenour
Vice President, Western Zone Sales
Wyeth Pharmaceuticals

David Ridenour has been employed by Wyeth for 29 years and has a held a number of positions in the commercial organization. For the past 13 years, David has been a Vice President with responsibilities for both Marketing and Sales. David has launched over 20 brands for Wyeth including Effexor and XR, Enbrel, Lodine, and most recently Pristiq.

David is married and he and his wife Kathleen have two daughters.

Clint has worked in the pharmaceutical industry and at Pfizer, the world’s largest research-based pharmaceutical company for almost 20 years, and has held key positions of increasing responsibility in the areas of sales, training, sales management, marketing and general management. He is based at Pfizer’s world headquarters in New York City.

Clint recently assumed the position of President, U.S. Operations, Pfizer Animal Health (PAH). In this role, Clint oversees the management of the livestock and companion animal businesses in the United States, currently the largest region in PAH with over $1 billion in revenues in 2006. Pfizer Animal Health is the #1 pharmaceutical company in this sector. As a member of the Animal Health Leadership Team, Clint also plays a critical role in strategy, planning and development for PAH. Prior to this position, Clint was the Vice President & General Manager for Pfizer’s U.S. Anti-Infectives/HIV Business Unit.

Clint Lewis began his career with Pfizer in 1988 as a sales representative in Long Island, NY. In 1991, he was promoted to the Pharmaceuticals Training Department. In 1992 Clint was promoted to District Manager Brooklyn, NY. In 1995, Clint was promoted to marketing as Product Manager for Cardura (a top selling product for Benign Prostatic Hyperplasia or “BPH”). In 1996, he was promoted to Regional Manager based in the Northeast. In 1999, Clint was promoted to General Manager, Pfizer Caribbean. In 2000, Clint was promoted to Vice President of Sales for the Parke Davis 3 Division. In 2005, Clint was promoted to Senior Vice President-Sales for the U.S. Learning & Development Organization. In January, 2006, Clint assumed the role of SVP of Sales for the U.S. Neuroscience Therapeutic Cluster.

During his tenure at Pfizer, Clint has achieved numerous honors including District Manager of the Year and has twice earned the Regional Manager of the Year award. During his time as General Manager in the Caribbean, Pfizer was named the #1 Pharmaceutical Company (in terms of total sales).

In addition to his current professional responsibilities, Clint is a member of the Board of Trustees for his alma mater, Fairfield University. He is a board member and ardent supporter of INROADS, Inc., volunteering his time with the Northeast Region affiliate. Clint also serves as a member of the Advisory Council for the School of Business and the MBA Program for the University of the Sciences in Philadelphia. He is also a member of Kappa Alpha Psi Fraternity, Inc.

Clint holds a BS degree in Biology from Fairfield University, Fairfield, CT and an MBA in Marketing from Fairleigh Dickinson University, Hackensack, NJ. Clint is married to Teresa and has two sons, Alex and Evan and a daughter, Eliana. He enjoys golf, teaching, drawing and reading business publications.

Bruce Braughton is the Associate VP heading up the commercial efforts for the Alliance between UCB, Inc. & sanofi-aventis for the launch of XYZAL.   He joined sanofi-aventis in September 1991 and has held several positions within the commercial organization including Sales Professional, Hospital Sales, Preceptor in Sales Training & Marketing, District Sales Manager, Sr. Manager of Critical Care Sales Training, and several roles in Marketing where he was most recently the head of Urology Marketing before joining the Allergy Business Unit.  Bruce has won several awards during his career including “ring” every year of eligibility, the Excellence in Leadership Award in both 1998 & 1999, and most recently the winner of the 2005 Marketing Excellence Award.

Bruce earned a BS degree in Marketing from Bloomsburg University and an MBA concentrating in Management from Bucknell University. 

Mike Capaldi is Associate Vice President, Sales Training & Leadership Development for sanofi-aventis, the world’s third largest pharmaceutical company that offers innovative products in a number of therapeutic categories. Mike is based in the Bridgewater, NJ United States headquarters and is in his tenth year with the organization.

Responsible for all training and development of nearly 10,000 field and headquarter-based employees, has directed the implementation of all phases of training for groups including Sales Professionals, Sales Leadership, Field Medical, Account Management and Brand Management teams. Programs are heavily focused on continuous improvement initiatives and individual development leading to overall organization performance enhancement. In 2006 & 2007, sanofi-aventis was recognized by the American Society of Training & Development (ASTD) as one of industry’s ‘Best’ learning organizations.

Involved in Training & Development for over eight years, Mike is a member of ASTD and a member of the Society of Pharmaceutical and Biotech Trainers Board of Directors. In 2007, he earned a Masters of Education in Corporate Training & Knowledge Management from Jones International University.

Liliana Gil
Worldwide Director of Marketing Services and Hispanic Marketing Strategy Lead
Johnson & Johnson

Liliana A. Gil works at Johnson & Johnson as the Director of Worldwide Marketing Services Souring providing category leadership for the management of Advertising Agencies on behalf of the Johnson & Johnson Family of Companies.

In addition to her role, for the last three-years, Lili has lead Johnson & Johnson’s “Proyecto MAS2”, an initiative focused on leveraging resources to bring increased visibility to the growing importance of the Hispanic segment. This initiative has pioneer an effort at J&J to bring together a comprehensive business case for corporation. She has directly worked with brands like: Topamax, Levaquin, Tylenol, Lactaid, Splenda, Johnson’s Baby, among others.

Since joining J&J in 2000 she has held positions of increased responsibility in the areas of Information Management, Internal Supply Chain and Strategic Sourcing. Prior to J&J she worked at Celebration Health- Walt Disney World in Orlando, Florida and Huguley Healthcare Systems in Texas.

In 2001 Lili was one of the founders of J&J’s Hispanic Organization for Leadership and Achievement (HOLA). To this date, HOLA has grown to become a very influential and active organization with over 30 chapters nation wide, 2 internationally, and over 1,000 members.

Her contributions have been recognized internally and externally. In 2007 she was recognized by the Chairman of the Board with the 2007 Marketing Excellence Award for her leadership in Hispanic Marketing across J&J, and received two Leadership Awards for her contributions to Global Diversity and Inclusion at J&J. In 2007 she was also the recipient of the “2007 Colombia Exterior a la Excelencia” (2007 Colombian Excellence Award), which recognizes outstanding Colombian professionals in the U.S. and their achievements in support of business, healthcare and the community. In 2006 received the J&J Supplier Diversity Outreach Award.

Originally from Colombia, Lili holds a Bachelor’s degree in Business Finance from Southwestern University. She has also completed foreign studies at Deakin University in Melbourne, Australia, completed post-graduate studies at Rollins College and holds a MBA from the University of Colorado.

Roles and Responsibilities - To lead the organization in development of innovative applications, which enable improved field sales efficiency while simultaneously improving marketing effectiveness. Primarily through the use of our Sales Force Automation system but also leading consideration of other applications.

Jennifer Cerny started her career in the pharmaceutical industry over 13 years ago and is within B.I. over 8 years now. After having been Marketing & Sales Head in Austria responsible for the Central Eastern European countries, she is currently located at the Corporate Headquarter in Ingelheim in Area Management Europe for Consumer Health Care.
Her main focus is to ensure the global strategy is implemented in her assigned countries accelerating the growth of the B.I. International Core Brands. Also it is an essential task to ensure that sales efficieny initiatives are in place and shared. She was also in the responsible team to kick-off and roll-out globally Customer Value Management principles within Consumer Health Care in B.I.

John graduated from the University of Connecticut in May 1985 and was commissioned as a 2nd Lieutenant in the United States Army. Following graduation, he spent four years on active duty stationed at Ft Hood, Texas. John continued his military service in the Army Reserves; being mobilized in 1990 for Desert Storm and served in the Gulf for 5 months. John completed his Military service in April 2004, as a Major.

John began his pharmaceutical career as a sales representative in March 1993 and his career has been highlighted by a progression of promotions and successes in field sales, management and training.

In April 2004 John took over leadership of the Sales Training Department at Daiichi Sankyo, where they have helped facilitate a 416% sales force expansion of over the last 4 years while leading a 250% expansion of the training group and driving the design and building of the new 30,000 square foot DSI Learning and Conference Center.

John has been a guest speaker, moderator, and panelist at several Society of Pharmaceutical & Biotech Trainers conferences, Drug Information Agency and Pharmaceutical Executive annual meetings, as well as a number of other sales and training conferences and webinars.

John and his wife Valerie currently reside in Connecticut with their two Golden Retrievers, Tucker and Buffy.

Ramesh Krishnan
Director, Marketing Science
Wyeth Pharmaceuticals

Ramesh Krishnan is Director - Marketing Science at Wyeth Pharmaceuticals. He is responsible for the promotion-mix modeling that are critical inputs into brand and portfolio planning processes. Through his experience in both consulting and client organizations, he has a broad understanding of the business issues in the pharmaceutical industry, and is proficient in applying econometric and statistical modeling to a wide array of problems in the areas of promotion response and resource optimization, segmentation, forecasting, and customer interaction modeling. He has also worked in tactical areas such as sales force alignment, call planning, and incentive compensation. In addition to an MBA, he holds a PhD in International Economics from Lehigh University.

Carolyn Rogers
PMP, RTP & SCS Plan Manager, Sales Incentive Management
GlaxoSmithKline

Carolyn Rogers is a successful Project Management Professional (PMP) with over 8 years of project management and team leadership experience in a fast-paced high-visibility sales support environment, and over 12 years IT experience in the implementation of business applications in the pharmaceutical, health, and defense industries.  Most recently in the last three years, she has functioned as the GlaxoSmithKline Incentive Compensation Plan Manager for two divisions.  Her extensive working knowledge of incentive compensation and pharmaceutical field sales & data allow her to effectively manage the plans that motivate almost half of the GSK pharmaceutical sales force.

Vladimir Velednitsky developed his Pharmaceutical Expertise in Horizon Systems Company as Director of Analytical Consulting Services. Besides creating new data management and information delivery tools, he was focusing on Business Management Consulting in optimizing sales performance through sales force structure, targeting strategies, performance metrics and incentive compensation. Vladimir’s wide range of clients included pharmaceutical companies of all sizes and products at all stages of their lifecycle.

Vladimir Velednitsky works at Pfizer for the last 7 years. He developed a targeting strategy for a newly restructured sales organization, provided analytical support for a company-wide sales targeting initiative, developed new sales performance metrics and reports, created new analytical methods in support of managed care contracting decisions. Currently provides analytical support to vendor management initiative.

Larry Pickett
Vice President & CIO
Purdue Pharma

Larry Pickett is Vice President and Chief Information Officer for Purdue Pharma L.P., a research-based pharmaceutical company located in Stamford, CT. He has been at Purdue for eleven years, and has responsibility for all information technology functions including IT strategy, business process transformation, technology infrastructure, and applications development. Mr. Pickett has led the company's implementation of core business systems and international research and development systems through a period of rapid company growth including a successful on-time, under-budget implementation of SAP. Current areas of focus include Sales Force Effectiveness, RFID, lowering the cost of IT through performance management benchmarking and best practices, and adding competitive advantage through business process optimization.

Mr. Pickett is a founding member of the Westchester/Fairfield chapter of the Society for Information Management. He is active with the Pharmaceutical Information Systems Association (PISA), an association of CIOs in the pharmaceutical industry, and has served on the IMPACC committee within the PhRMA organization. Mr. Pickett was formerly with Merck and Company, Glaxo Welcome, and GE, prior to joining Purdue. He earned his Bachelors degree from the University of North Carolina at Chapel Hill and MBA from the University of North Carolina at Greensboro.

Donald Hribek currently is the Vice President of Strategic Accounts of Endocrinology at EMD Serono, Rockland, MA and is responsible for covering and managing three disease therapeutic areas.  These include, Reproductive Health and Metabolic Endocrinology.  During his 15 years at EMD Serono, he has held the positions of Vice President of Sales, Metabolic Endocrinology: Area Business Director for Reproductive Health in New England, Executive Director of Sales, Regional Sales Director and Customer Service Manager.  Prior to joining to the pharmaceutical industry he was worked for 10 years for Vistakon, a Johnson & Johnson Company.  He holds degrees from Central Michigan University, The University of Michigan and an MBA from the University of Michigan.  

Carol Wells
Senior Director, Commercial Training & Development
Genentech

Over twenty-nine years of sales, sales management, marketing, account management, and training experience. Strong performance and outstanding results have been achieved through substantial experience and skill in the following areas: 

• Leadership/Sales Management • Sales and Management Training • Team Building/People Development • Marketing • Turnaround Management • Creativity/Innovation/Process Re-engineering • Strategic Planning • Recruiting/Staffing • Budget Management

Vice President, SPBT Board of Directors; Senior Director of Commercial Training and Development, Genentech, oversees Sales and Functional Skills Training, including Compliance and Management Development.
 
History at a Glance:
Sr. Director, Commercial Training & Development at Genentech
Marion, HRM, Elan
Wellesley College, BA
Rockhurst College, MBA

Sales, Sales Management, Account Management, Marketing and Training experience.
Accomplishments as Sr. Director, Commercial Training & Development at Genentech:
·       Established consistent onboarding and training New Hires
·       Introduced common frameworks such as Adaptive Selling, Evidenced Based Medicine, Coaching Model and Style Differentiator
·       Built Management Marketing and Leadership Curriculum for Emerging Managers through Sr. Directors/Vice President
·       Responsible for effective Compliance Training

Sylvia is the GM, US Commercial Operations, Ipsen Pharmaceuticals. With more than 30 years of pharmaceutical sales and marketing experience, Sylvia held the position of Senior Vice President and Head of US for Vernalis (a British based Biopharmaceutical company). Vernalis was acquired by Ipsen in July, 2008. In this position, she established and led a US commercial organization focused on the neurology therapeutic area. Previous positions included, Executive Vice President, Branded Pharmaceuticals, at Andrx, running a 500+ organization. Prior to that, Sylvia was employed by Pharmacia as Global Vice President of Marketing for Bextra®, where she was instrumental in leading one of the most successful launches in the U.S. She was also was recognized for her leadership in growing market share for Mirapex® while serving as Global Vice President, Marketing, for neurology products. Previous to this she held various positions in sales at Upjohn. Sylvia has a BS in Biology and an MBA in Marketing.

Rick Henson is currently the VP of Sales for Vernalis Pharmaceuticals, a specialty company focused in neuromuscular disease. He has over 29 years of pharmaceutical experience with 14 of it at the senior management level. This experience has focused largely on start up pharmaceutical commercial opportunities, where he has started up four successful entities.

29 year veteran of the pharmaceutical industry. Began career with Riker Laboratories, which later became 3M Pharmaceuticals, as a sales rep. in Cape Girardeau Mo.. Held various positions of increasing responsibility including District Manager, National Account Manager, National Manager of Managed Care, National Manager of Trade Relations, Managed Care and Government Affairs, and Regional Business Director Southeast during 19 years with 3M. Joined UCB in Atlanta in 1998 as Director of Trade Relations and Managed Care and was named National Sales Director for the Respiratory Pediatric Business Unit in 2001. For the past 8 years has led the 450 person UCB Respiratory Pediatric sales force through two major acquisitions and numerous co-promotes with companies such as Pfizer, Elan, Connetics, Teva, and sanofi/aventis. Currently sits on the Joint Operating Committee of both current UCB co-promotes.with Teva and sanofi/Aventis and is a member of the UCB Global Leadership team. Also currently sits on the Board of Directors of the Mercer School of Pharmacy and Health Sciences.

Jeremy Jaggi is Director - Marketing Strategy, Segments and Operations at Amgen Incorporated. He is responsible for the one to three year promotional-mix strategy as well as reimbursement and channels operations. Through his experiences in marketing analytics, sales management, sales force operations leadership and brand marketing he has a unique understanding of co-optation and synchronicity of large and small molecule co-promotion. He has been a change-agent for e-marketing and efficiency initiatives throughout his career. In addition to his degree in Health Sciences, Jeremy holds an MBA from the Graziadio School of Management at Pepperdine University.

Mike Ziskin
Senior Director, Public Payer Policy Strategy & Marketing
Centocor Inc.  

Michael Ziskind is a Director for Public Policy and Payer Strategy at Centocor Ortho Biotech Services, LLC. where he is responsible for developing and implementing strategies to address policy and public payer issues. Since coming to Centocor in 1998, Mike has played many roles supporting payer launch, reimbursement support, and marketing activities for Remicade and other products in development. He has also played a significant role in development strategies to address various Medicare payment coding and payment issues that affect physicians and hospitals.

Prior to going to Centocor, Mike was a Principal Consultant for Covance Health Economics and Outcomes Services. In that role he developed strategic payer market strategies and conducted product assessment for many biologic, pharmaceutical, and device manufacturers.

Mike Pusateri
Senior Director, Nephrology Sales
Watson Pharmaceuticals

Kelly has 20 years experience in the pharmaceutical industry. She is currently a Regional Business Director for the Pharmaceutical Division of Bausch & Lomb. Prior to joining Bausch & Lomb, Kelly was a Sr. District Sales Manager at Schering-Plough where she worked closely with the Merck/Schering-Plough (MSP) joint venture. She has served as the lead on several committees for the (MSP) joint venture, as well as Marketing and Sales Operations. She has experience with selling in many markets including cardiovascular, pulmonary, allergy, anti-infectives, dermatology and most recently ophthalmics. She served as regional trainer working with new sales managers in the Northeast. Kelly has a B.S. Degree in Business Administration from the College of St. Elizabeth in New Jersey.

Jerry is currently Vice President, Commercial Operations for NuPathe Inc., NuPathe is a privately-held specialty pharmaceutical company, located in Conshohocken, PA.  NuPathe specializes in the development of therapeutic products for neurological and psychiatric diseases.  In this position, Jerry leads all commercial efforts for the current portfolio as well as L&A opportunities.  Current focus is on the pre-commercial efforts in support of NP101, a novel transdermal formulation for the treatment of acute migraine currently in Phase III clinical trials.

Prior to joining NuPathe, Jerry held the position of Senior Director, Strategic Marketing at Endo Pharmaceuticals.  In his previous assignment at Endo, Jerry served as a Regional Sales Director during which time he led a team of managers and sales representatives through a major sales force expansion and the commercial launch of two products.  Jerry joined Endo in 2001 as a Marketing Director and subsequently served as Group Marketing Director, Pain Products from 2002 to 2005.  During this assignment he managed a portfolio of marketed products including Lidoderm® and Percocet® as well as drug development candidates within the pain segment. 

Jerry spent the first 11 years of his career with Merck & Co. Inc. in a variety of sales and marketing positions of increasing responsibility.  These assignments included Associate Director of Marketing, Worldwide New Products Planning for Anti-Infectives, Marketing Manager for Vioxx® and Market Research Analyst for Proscar® and Propecia®.  Jerry holds a B.A. in Economics from Dickinson College and an M.B.A. from Villanova University.  

Kenneth Harris serves as Senior Director, Sales Leadership Development for Shire Pharmaceuticals. In this capacity, Harris is responsible for the strategic development and execution of all learning initiatives for Shire’s Sales Leaders globally. He also works closely with multi-functional teams within Shire to ensure alignment with the goals of the organization.

Previously, Ken served as Senior Director, US Specialty Pharma Sales Training where he oversaw numerous product launches, sales force expansions and the restructuring into business units.
He has more than 17 years of experience in sales, management, and training. Currently, Ken is developing training programs and curriculum. Prior to joining Shire, Harris was in sales and management at Sankyo-Parke Davis, Astra and started his career in the consumer goods industry.

Ken holds a Bachelor‘s degree in Business Administrations from California State University, Hayward. He has received numerous certifications and is also a current member of the Society of Training and Development and the Society of Pharmaceutical and Biotech Trainers.

Paul Stickler is senior director of sales at OVATION Pharmaceuticals and oversees the company’s fast-growing specialty sales force. 

Prior to joining OVATION in 2006, Mr. Stickler spent 15 years in the sales and marketing organization at Abbott Laboratories where he held several roles of increasing responsibility. After starting in primary care as a product specialist selling a wide range of the company’s products and a representative selling anti-infectives, Mr. Stickler moved into specialty sales, serving as a representative, sales training program manager and district sales manager.

Leveraging his sales experience, Mr. Stickler then moved into product management in the neurosciences for several years, overseeing and managing several award-winning programs, before returning to sales as a regional sales manager in Abbott’s cardiology and cardiology specialty sales groups.

With numerous awards and recognitions for his innovative approach to sales and outstanding teamwork skills, Mr. Stickler has demonstrated his ability to lead teams to deliver outstanding performance.

Mr. Stickler received his bachelor’s degree in political science from Purdue University.

Vyom Bhuta
Director, Business Analysis & Decision Support
Otsuka America Pharmaceutical, Inc.

Vyom joined Otsuka in 2005 and currently serves as Director of Director Business Analysis and Decision Support, responsible for Market Intelligence and Sales Operations functions across the organization which includes Oncology, Neuroscience and Cardiovascular franchise and the Medical Device & Diagnostic business unit. Decision support areas include business planning and development for new markets and products, product portfolio optimization, market research, sales force structure and sizing, customer segmentation and targeting, forecasting, incentive compensation, sample accountability, business analytics, and compliance state reporting.

Prior to joining Otsuka, Vyom worked for various management consulting companies including PricewaterhouseCoopers with a focus on customer strategy, processes and support for Life Sciences companies in US and Asia Pacific regions. Vyom holds a B.A in Finance and Marketing and an M.S. in Business Information.

Israel Garcia Crespo
General Manager in Almirall SA de CV
Almirall

With 250 collaborators and 37 Mill USD, the main objective is to achieve the annual objectives and to prepare the MC to assume the important challenges in the mid term. The most important milestone for the Company is the launch of a new product, I+D Almirall, in the COPD field. To have for 2010 the correct structure and a team well trained is the most important objective in this new professional challenge

Norbert Stone
National Senior Director of Sales & Marketing Training
Astellas

Michael Torres
Field Director
Ferring Pharma

My Pharma career began with Astra Merck selling Prilosec (GI) and Plendil (CV) in June 1992.

I was then promoted to a Sales Analyst (11/1997) and then promoted to a marketing position responsible for the West part of the US.

In 1999, I moved back into the field as a DM in New Orleans.

I’ve had a total of 7 years of DM experience to include Biovail in Schwarz Pharma (both sales forces were purchased by bigger companies). I was at Schwarz for almost 3 years where I took a team from 22 out of 22 to #1 in less than 7 months and remained in the top 2 (mostly #1) for the next 7 out of 8 quarters.

I then joined Ferring as a specialty Manager in the new Orthopaedic division in July 2005. I was then promoted to the Associate National Field Director spot for 2007. In early 2008 (March), the Sales Force Effectiveness team was developed and I was appointed the Director; reporting to Olivier Delannoy.

The Ferring Sales Force Effectiveness Team has lead initiatives such as: Business Unit integration, new Sales Force Automation platform, revamping of territory alignments, overhauling of the new hire training program (including new field training), retention initiatives, Compliance initiatives and Manager Development (to name a few). The department consists of: 2 Sales Analysts, 2 Training Managers and a Director of Sales Training.

Hans Nagl
Senior Manager
Shire

Hans Nagl currently holds the position of Senior Manager at Shire plc. located outside of Philadelphia, Pennsylvania in the United States of America. He is responsible for analytics around promotional resource optimization enabling financial tradeoff decisions between promotional channels. He also provides input and experience to issues around Sales Force optimization, targeting and implementing plans and strategies in the United States and Europe.

Hans has worked in healthcare-related industries for over 20 years, both on the consulting and the client side, in the United States, Europe and Japan. He has held positions with AstraZeneca, IMS Health and Pennsylvania Hospital, the oldest hospital in the United States. He is also a Board Member of the Philadelphia-Japan Health Sciences Dialogue which enhances awareness of healthcare and life science issues and opportunities that exist in Japan and the United States.

Hans was born in Vienna, Austria, where he spent his childhood. After moving to the United States in 1984, Hans obtained his Bachelor of Science degree from Saint Joseph’s University in Philadelphia, Pennsylvania and a Masters of Science degree in Engineering Sciences at Penn State University.

Subhash Vaid is Vice President of Global Product Management and Strategy at Dendrite International. He joined the company in 2005 and is responsible for developing the strategy for the company's product and services portfolio.

Mr. Vaid comes to Dendrite with a strong and successful track record in setting up customer strategy solutions and services at startups as well as established retail, technology and software companies. From 2002-2005 Mr. Vaid served at Sears Roebuck and Company as Director of their CRM strategy. He was responsible for creating and optimizing a process for collecting customer insights and translating them into strategic merchandising and marketing plans.

Prior to Sears, from 1999-2002, Mr. Vaid served as the Vice President of eCommerce at Acxiom Corporation where he successfully developed and executed a corporate-wide eCommerce and CRM solution based strategy. During his tenure at Acxiom, Mr. Vaid was responsible for creating industry specific package solutions for the credit card, insurance, brokerage healthcare, retail, telecommunications and manufacturing industries.

Mr. Vaid’s previous experience includes developing corporate-wide sales, marketing and product strategy for a startup company. He also spent several years in the telecom sector at Verizon Communications (1995-1998) and AT&T (1990-1995) where he successfully developed and executed customer retention strategies that lead to increases in sales.

Mr. Vaid has an MS in Economics from the New School of Social Research in New York as well as a Master of Regional Planning from Middle East Technical University in Ankara, Turkey. He is currently a Ph. D. Candidate in Economics/Econometrics, pursuing a program at the New School for Social Research in New York.

Mr.Gleason is a leader in building new physician access strategies and technologies. He has been a marketer and strategy consultant specializing in pharmaceutical sales and marketing including physician access strategies and new access and eMarketing technologies. He has worked with Bristol-Myers Squibb, directing Global New Business Development, and consulted with Johnson & Johnson, Pfizer, Pharmacia, Searle, Abbott, SmithKline Beecham, Allscripts among others. He was a key strategic resource for some of the most successful new drug launches in history. Mr. Gleason is a regular speaker and writer on pharmaceutical sales and marketing.

Angela Bakker Lee is a Principal with ZS Associates, a management consulting firm specializing in sales and marketing, with 17 offices worldwide and clients in ~70 countries. Angela is global leader for the firm's Productivity and Effectiveness practice. In that capacity she works with ZS clients to identify and diagnose key drivers of productivity impacting Sales, Marketing and Clinical Development, partnering with them to achieve the changes necessary to improve performance. She has served the pharmaceutical industry as a management consultant for the past ten years and is a frequent speaker on the topic of Sales Force Effectiveness, as well as contributing to published articles on the subject.

Patrick Homer joined SAS as Life Sciences Sales and Marketing Practice Principal after nearly 20 years of experience in the commercial field of the pharmaceutical industry. At SAS, Patrick is responsible for introducing advanced commercial analytical strategies into sales and marketing divisions of the Pharmaceutical Industry.

Prior to joining SAS, Patrick was a business development director at Innovex Limited, the commercial division of Quintiles, providing outsourced salesforce solutions and salesforce effectiveness initiatives to the pharmaceutical and healthcare industry. Patrick also worked as a national sales manager, building and running four national sales teams.

Over the course of his career, Patrick has worked on more than 70 outsourced salesforce projects from more than 30 customers and has played a leading role in introducing salesforce effectiveness strategies, predictive analytics and dashboard technologies to his clients. He holds a master’s degree in business administration, with majors in strategy and marketing, from University College of Cardiff Business School and a bachelor’s degree in microbiology from University College of Swansea.

Twenty-four years of experience in the development and presentation of unique sales and management training workshops and medical education events.

With a special emphasis on Leadership Development programs for every managerial level, Janet has worked on every aspect of SIMULATIONS, Inc.’s projects throughout her tenure with the organization. A graduate of Trenton State College, now the College of New Jersey, and a member of ASTD, she is also a member of the Screen Actors Guild and Actors Equity Association.

With a degree in education and a life-long focus in theatrical performance, her work in educational events for the healthcare industry affords her a unique insight into the most effective adult learning modalities.

John is a multi-disciplined professional with a broad range of experience in the pharmaceutical information services industry. Since 1990 John has held senior positions in the finance, sales, marketing and operations functions of leading research and information agencies, including: Scott-Levin Associates, NDC Health and Market Measures / Cozint. His experience spans primary and secondary research, proprietary solutions and syndicated products designed to meet the most challenging needs of pharmaceutical sales management, brand management and marketing research clients.

John joined ImpactRx at its inception in 2000, and was an instrumental member of the team that developed the company’s innovative research design and unique products.

Garry O’Grady is Senior Vice President and head of the Sales Practice at Campbell Alliance. Before joining the firm, Mr. O’Grady was a member of the Surgical Products Division of Olympus America, Inc., where he sold capital products used in minimally invasive surgery. As a member of the Urology Products Marketing Team, he distinguished himself as a member of Olympus’s top sales group. Mr. O’Grady also served as a sales representative for Ciba-Geigy and was a member of Ciba’s Circle of Excellence. Prior to his pharma positions, Mr. O’Grady was an officer in the United States Army from 1987 to 1992. Mr. O’Grady received his MBA from the University of North Carolina at Chapel Hill and earned his BS from the United States Military Academy, West Point.

Bob Merold is General Manager of the Symphony Metreo Pharmaceutical Division, a subsidiary of the $2.5B Symphony Technology Group. STG brings technology solutions and decision support applications to real business problems deployed globally in over a dozen Fortune 100 firms. As a senior executive at IMS Health in the 1990’s, Bob develop and led to market leadership the most widely used information service in the industry, the Xponent suite of products, in both America and Europe. Over the past decade he’s consulted for numerous data and technology companies and venture capital firms, in the process working with virtually every major multi-national pharmaceutical firm. Bob has served as an industry expert to The Symphony Technology Group for four years and believes Symphony-Metreo will create great value in solving numerous key business problems in pharmaceutical and biotech companies. Bob also has held management positions at Procter & Gamble and Bristol-Myers Squibb. His is a graduate of the University of Pennsylvania.

Mr. Corby joined HPR in 2005 and brings a breadth of client side experience from over 30 years in the industry. He provides strategic insight to HPR’s analytic and market research processes with an eye towards tactical implementation by clients to realize a competitive advantage.

Prior to joining HPR, Mr. Corby was with Sanofi-Aventis Pharmaceuticals where he held numerous leadership positions. These include Vice President of Rheumatology & Endocrinology Sales as well as heading the New Products Commercialization group responsible for the commercial optimization of metabolism products in development. Other experience includes Senior Director of Customer Segment Marketing for Rhone-Poulenc Rorer Pharmaceuticals which involved extensive work in managed markets as well as Director of Worldwide Marketing for Dermik Laboratories.

Mr. Corby has a BA in Biology from Saint Michael’s College in Vermont and an MBA in Marketing from Rutgers University.

Joe DosSantos is Senior Director, Field Solutions at Siperian, an Innovative Provider of Master Data Management Solutions.

In this capacity, Mr. DosSantos has helped dozens of clients create business cases that detail how Master Data Management can address their business needs.

Carl provides a distinctive 360 degree perspective spanning all aspects of global healthcare. Over his 30 year career, he has served as a clinical practitioner and within for and not-for-profit entities.

Carl’s segment experience includes: biopharmaceutical, consumer, medical device, diagnostics, vaccines, veterinary, dental and dietary supplements spanning branded/generic products, over/behind/under the counter brands, conventional/alternative delivery forms and prescription to over-the-counter and self genericization initiatives.

Carl most recently was Director Life Sciences/Healthcare at Proactive Worldwide, a global specialty competitive intelligence/decision support firm and has been in progressive management positions with Marketing Technology Solutions/QualityHealth.com, AmericasDoctor/Essential Group CRO, The United States Pharmacopeia, Pharmacia/G.D. Searle, Boots Pharmaceuticals, Flint Laboratories (Baxter Corporation), Health Systems Projects, Dimensional Marketing/Advertising. and Derenfeld and Associates Consulting.

Mr. Derenfeld holds a Master's in Business Administration from the J.L. Kellogg School of Management, Northwestern University, and a Master's of Social Work from the Wurzweiler School, Yeshiva University, and a Bachelor of Arts from SUNY at Stony Brook. Mr. Derenfeld is a member of the J.L. Kellogg Alumni interviewing team, and the Gerson Lehrman and DeMatteo Monness consulting groups.